134 related articles for article (PubMed ID: 11000467)
1. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili.
Eko FO; Mayr UB; Attridge SR; Lubitz W
J Biotechnol; 2000 Sep; 83(1-2):115-23. PubMed ID: 11000467
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
Jonson G; Osek J; Svennerholm AM; Holmgren J
Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.
Attridge SR; Voss E; Manning PA
J Biotechnol; 1999 Aug; 73(2-3):109-17. PubMed ID: 10486921
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.
Hall RH; Losonsky G; Silveira AP; Taylor RK; Mekalanos JJ; Witham ND; Levine MM
Infect Immun; 1991 Jul; 59(7):2508-12. PubMed ID: 1711017
[TBL] [Abstract][Full Text] [Related]
6. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
Sharma DP; Thomas C; Hall RH; Levine MM; Attridge SR
Vaccine; 1989 Oct; 7(5):451-6. PubMed ID: 2573216
[TBL] [Abstract][Full Text] [Related]
7. Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera.
Osek J; Jonson G; Svennerholm AM; Holmgren J
Infect Immun; 1994 Jul; 62(7):2901-7. PubMed ID: 7911787
[TBL] [Abstract][Full Text] [Related]
8. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili.
Dalsgaard A; Serichantalergs O; Forslund A; Lin W; Mekalanos J; Mintz E; Shimada T; Wells JG
J Clin Microbiol; 2001 Nov; 39(11):4086-92. PubMed ID: 11682534
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay for determination of antibodies to Vibrio cholerae toxin-coregulated pili.
Osek J; Jonson G; Svennerholm AM; Holmgren J
APMIS; 1992 Nov; 100(11):1027-32. PubMed ID: 1361754
[TBL] [Abstract][Full Text] [Related]
10. [Purification and identification of pili of Vibrio cholera O139].
Du Y; Jia W; Liu C
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):28-30. PubMed ID: 12205915
[TBL] [Abstract][Full Text] [Related]
11. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
Smirnova NI; Livanova LF; Chekhovskaia GV; Eroshenko GA; Lazovskiĭ IuV; Zakharova TL
Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874
[TBL] [Abstract][Full Text] [Related]
12. The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model.
Sharma DP; Stroeher UH; Thomas CJ; Manning PA; Attridge SR
Microb Pathog; 1989 Dec; 7(6):437-48. PubMed ID: 2576091
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
Bondre VP; Sinha VB; Srivastava BS
FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
[TBL] [Abstract][Full Text] [Related]
14. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.
Voss E; Manning PA; Attridge SR
Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675
[TBL] [Abstract][Full Text] [Related]
15. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF
Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
[TBL] [Abstract][Full Text] [Related]
17. Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development.
Eko FO; Szostak MP; Wanner G; Lubitz W
Vaccine; 1994 Oct; 12(13):1231-7. PubMed ID: 7530888
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
[TBL] [Abstract][Full Text] [Related]
19. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo.
Jonson G; Holmgren J; Svennerholm AM
Infect Immun; 1992 Oct; 60(10):4278-84. PubMed ID: 1356927
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a new variant of toxin-coregulated pilus protein (TcpA) in a toxigenic non-O1/Non-O139 strain of Vibrio cholerae.
Nandi B; Nandy RK; Vicente AC; Ghose AC
Infect Immun; 2000 Feb; 68(2):948-52. PubMed ID: 10639469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
